PIK3CA and breast cancer: This study showed that PIK3CA mutations were more frequent in low-risk luminal breast cancer and were associated with significantly improved 5-year distant relapse-free survival in univariate analysis (HR, 0.76; 95% CI, 0.63–0.91; P = 0.003) [29].